Crigler-Najjar Syndrome, Type I (CN1)

Alias:

Crigler-Najjar Syndrome

Crigler-Najjar Syndrome Type 1

Bilirubin Uridinediphosphate Glucuronosyltransferase Deficiency Type 1

Bilirubin Uridinediphosphate Glucuronosyltransferase Deficiency

Bilirubin Udp Glucuronyl Transferase Deficiency

Bilirubin-Ugt Deficiency Type 1

Bilirubin-Ugt Deficiency

Crigler Najjar Syndrome

Familial Nonhemolytic Unconjugated Hyperbilirubinemia

Bilirubin Glucuronosyltransferase Deficiency

Hereditary Unconjugated Hyperbilirubinaemia

Hereditary Unconjugated Hyperbilirubinemia

Hyperbilirubinemia, Crigler-Najjar Type I

Congenital Familial Nonhemolytic Jaundice

Deficiency of Glucuronosyltransferase

Udp Glucuronyl Transferase Deficiency

Crigler-Najjar Disease or Syndrome

Glucuronyl Transferase Deficiency

Glucuronyltransferase Deficiency

Crigler Najjar Syndrome, Type 1

Cns - [crigler-Najjar Syndrome]

Crigler-Najjar Syndrome Type I

Crigler-Najjar Syndrome 1

Ugt Deficiency

Hblrcn1

Cn-I

Cn1

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Crigler-Najjar Syndrome, Type I, also known as crigler-najjar syndrome, is related to crigler-najjar syndrome, type ii and cardiomyopathy, dilated, with hypergonadotropic hypogonadism. An important gene associated with Crigler-Najjar Syndrome, Type I is UGT1A1 (UDP Glucuronosyltransferase Family 1 Member A1), and among its related pathways/superpathways are Metabolism and Nuclear receptors meta-pathway. The drugs Carbamide peroxide and Liver Extracts have been mentioned in the context of this disorder. Affiliated tissues include Liver and brain, and related phenotypes are abnormality of the liver and jaundice

Related ID：

MALACARDS：CRG003

OMIM：218800

MESH：D003414

ICD11：291439191